Hiroyasu Hirose

677 total citations
16 papers, 505 citations indexed

About

Hiroyasu Hirose is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Hiroyasu Hirose has authored 16 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Hiroyasu Hirose's work include Neuropeptides and Animal Physiology (5 papers), Receptor Mechanisms and Signaling (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Hiroyasu Hirose is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Receptor Mechanisms and Signaling (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Hiroyasu Hirose collaborates with scholars based in Japan and United States. Hiroyasu Hirose's co-authors include Susumu Okabe, Koji Takeuchi, Akio Kanatani, Jun Suzuki, Takashi Shirakura, Masahiko Ito, Minoru Sasaki, Hisashi Iwaasa, Makoto Ito and Akane Ishihara and has published in prestigious journals such as Gastroenterology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Hiroyasu Hirose

16 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroyasu Hirose Japan	10	162	136	132	106	91	16	505
Helena Corominola Spain	13	291 1.8×	230 1.7×	189 1.4×	157 1.5×	100 1.1×	21	683
May C.M. Yang Taiwan	15	93 0.6×	153 1.1×	196 1.5×	88 0.8×	75 0.8×	32	573
P. Tso United States	11	61 0.4×	191 1.4×	177 1.3×	221 2.1×	125 1.4×	18	643
M. Dodson Michael United States	13	94 0.6×	134 1.0×	212 1.6×	293 2.8×	285 3.1×	19	592
Howard R. Sloan United States	16	76 0.5×	302 2.2×	336 2.5×	133 1.3×	74 0.8×	41	796
Stephan Sachs Germany	11	234 1.4×	264 1.9×	241 1.8×	125 1.2×	223 2.5×	15	721
Kazuyasu Maruyama Japan	12	218 1.3×	74 0.5×	230 1.7×	60 0.6×	115 1.3×	27	532
Fangfang Li China	14	115 0.7×	38 0.3×	158 1.2×	62 0.6×	20 0.2×	41	516
Masayasu Inoue Japan	12	58 0.4×	138 1.0×	173 1.3×	104 1.0×	34 0.4×	14	509

Countries citing papers authored by Hiroyasu Hirose

Since Specialization

Citations

This map shows the geographic impact of Hiroyasu Hirose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyasu Hirose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyasu Hirose more than expected).

Fields of papers citing papers by Hiroyasu Hirose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyasu Hirose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyasu Hirose. The network helps show where Hiroyasu Hirose may publish in the future.

Co-authorship network of co-authors of Hiroyasu Hirose

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyasu Hirose. A scholar is included among the top collaborators of Hiroyasu Hirose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyasu Hirose. Hiroyasu Hirose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hirose, Hiroyasu. (2012). BindingDB Entry 5312: Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.. PubMed. 297(2). 790–7. 6 indexed citations

Moriya, Ryuichi, Takashi Shirakura, Hiroyasu Hirose, et al.. (2009). NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice. Peptides. 31(4). 671–675. 24 indexed citations

Moriya, Ryuichi, Toru Fujikawa, Junko Itô, et al.. (2009). Pancreatic polypeptide enhances colonic muscle contraction and fecal output through neuropeptide Y Y4 receptor in mice. European Journal of Pharmacology. 627(1-3). 258–264. 19 indexed citations

Ito, Makoto, Jun Suzuki, Minoru Sasaki, et al.. (2007). Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet. Hepatology Research. 37(1). 50–57. 185 indexed citations

Hirose, Hiroyasu, Jian Jiang, & Masaru Nishikibe. (2003). Effects of Muscarinic Receptor Antagonists With or Without M2 Antagonist Activity on Cholinergic Reflex Bronchoconstriction in Ovalbumin-Sensitized and -Challenged Mice. Journal of Pharmacological Sciences. 92(3). 209–217. 2 indexed citations

Hirose, Hiroyasu, Ikuo Aoki, Toshifumi Kimura, et al.. (2002). The subtypes of muscarinic receptors for neurogenic bladder contraction in rats. European Journal of Pharmacology. 452(2). 245–253. 8 indexed citations

Hirose, Hiroyasu, Ikuo Aoki, Toshifumi Kimura, et al.. (2001). Pharmacological Properties of (2R)-N-[1-(6-Aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2- hydroxy-2-phenylacetamide: A Novel Muscarinic Antagonist with M2-Sparing Antagonistic Activity. Journal of Pharmacology and Experimental Therapeutics. 297(2). 790–797. 8 indexed citations

Hirose, Hiroyasu, Toshifumi Kimura, Megumu Okada, et al.. (2000). Antiplatelet and Antithrombotic Effects of a Novel Selective Phosphodiesterase 3 Inhibitor, NSP-513, in Mice and Rats. The Japanese Journal of Pharmacology. 82(3). 188–198. 10 indexed citations

Hirose, Hiroyasu, Satoshi Mashiko, Toshifumi Kimura, et al.. (2000). Antithrombotic Activity of NSP-513, a Novel Selective Phosphodiesterase 3 Inhibitor, on Femoral Arterial Thrombosis Induced by Physical Stenosis and Electrical Current: Comparison of Antithrombotic and Hemodynamic Effects. Journal of Cardiovascular Pharmacology. 35(4). 586–594. 8 indexed citations

10.

Mitsuya, Morihiro, Kensuke Kobayashi, Atsushi Satoh, et al.. (2000). A Potent, Long-Acting, Orally Active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A Novel Muscarinic M₃ Receptor Antagonist with High Selectivity for M₃ over M₂ Receptors. Journal of Medicinal Chemistry. 43(26). 5017–5029. 36 indexed citations

11.

Hirose, Hiroyasu, Tomio Sasaki, Masahiko Kobayashi, et al.. (1995). The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. European Journal of Pharmacology. 277(1). 77–87. 55 indexed citations

12.

Noguchi, Kazuhito, Yukiko Noguchi, Hiroyasu Hirose, et al.. (1993). Role of endothelin ETB receptors in bronchoconstrictor and vasoconstrictor responses in guinea pigs. European Journal of Pharmacology. 233(1). 47–51. 27 indexed citations

13.

Noguchi, Kazuhito, Takahiro Fukuroda, Hiroyasu Hirose, et al.. (1991). Local formation and degradation of endothelin-1 in guinea pig airway tissues. Biochemical and Biophysical Research Communications. 179(2). 830–835. 18 indexed citations

14.

Hirose, Hiroyasu, Koji Takeuchi, & Susumu Okabe. (1991). Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. Gastroenterology. 100(5). 1259–1265. 17 indexed citations

15.

Hirose, Hiroyasu, Koji Takeuchi, & Susumu Okabe. (1991). Effect of Indomethacin on Gastric Mucosal Blood Flow Around Acetic Acid-Induced Gastric Ulcers in Rats. Gastroenterology. 100(5). 1259–1265. 74 indexed citations

16.

Arai, Ichiro, et al.. (1987). Effects of indomethacin and cold-stress on gastric acid secretion and ulceration. The effects of anti-acid secretory agents in rats.. PubMed. 57(3). 313–27. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact